Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 7 2021

Full Issue

Warp Speed Adviser's Role Reduced In Biden Administration

Moncef Slaoui will act as a consultant for four to six weeks, the transition team said Wednesday.

Politico: Biden To Phase Out Operation Warp Speed Co-Leader 

The leaders of the Trump administration’s Operation Warp Speed will continue working on the vaccine rollout during the Biden administration, a transition official confirmed on Wednesday. But Moncef Slaoui, the chief scientific adviser to the government’s vaccine accelerator, won’t stay on for long. Slaoui will take on a reduced role as a consultant for four to six weeks before departing, according to a Biden transition official. Gen. Gustave Perna, Operation Warp Speed’s chief operating officer, will continue to control the logistics of vaccine distribution, the transition official said. (Roubein, 1/6)

Stat: Warp Speed’s Slaoui Will Stay On As A Consultant For Biden

Moncef Slaoui, the controversial head of Operation Warp Speed, will serve as a consultant in the Biden administration, he confirmed Wednesday. He suggested it would be a less active role than his current position, as the initiative’s chief adviser. (Florko, 1/6)

KHN: Listen: How Operation Warp Speed Became A Slow Walk 

KHN Editor-in-Chief Elisabeth Rosenthal appeared on Diane Rehm’s “On My Mind” podcast on NPR to discuss the bottlenecks that have prevented doses of precious covid-19 vaccine from making it from drugmakers’ factories into patients’ arms. It didn’t have to be this way, she explains. (Zuraw, 1/7)

In other political news —

The Washington Post: Some Americans Won't Get Their Stimulus Checks Until They File Their 2020 Taxes 

As the U.S. Treasury rushes to distribute second stimulus payments, many Americans learned this week that they will not receive the $600 until they file their 2020 tax return, a delay threatening additional hardship. (Long, 1/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF